These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12798845)

  • 1. [State and perspectives of the French haemovigilance system. Presentation of the data collected over 9 years].
    David B
    Transfus Clin Biol; 2003 Jun; 10(3):131-9. PubMed ID: 12798845
    [No Abstract]   [Full Text] [Related]  

  • 2. The French haemovigilance system.
    Noel L; Debeir J; Cosson A
    Vox Sang; 1998; 74 Suppl 2():441-5. PubMed ID: 9704479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of blood components prepared in the blood transfusion center/blood bank.
    Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemovigilance: concept, Europe and UK initiatives.
    McClelland B; Love E; Scott S; Williamson LM
    Vox Sang; 1998; 74 Suppl 2():431-9. PubMed ID: 9704478
    [No Abstract]   [Full Text] [Related]  

  • 5. The French haemovigilance system.
    Debeir J; Noel L; Aullen J; Frette C; Sari F; Mai MP; Cosson A
    Vox Sang; 1999; 77(2):77-81. PubMed ID: 10516551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of transfusion practice beyond the blood transfusion laboratory is essential to prevent ABO-incompatible death.
    Voak D; Chapman JF; Phillips P
    Transfus Med; 2000 Jun; 10(2):95-6. PubMed ID: 10849377
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion medicine issues in the practice of anesthesiology.
    Robblee JA; Crosby E
    Transfus Med Rev; 1995 Jan; 9(1):60-78. PubMed ID: 7719039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 10. Worldwide overview of existing haemovigilance systems.
    Faber JC
    Transfus Apher Sci; 2004 Oct; 31(2):99-110. PubMed ID: 15501414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemovigilance systems.
    Engelfriet CP; Reesink HW; Brand B; Lévy G; Williamson LM; Menitove JE; Heier HE; Jørgensen J; Politis C; Seyfried H; Smit Sibinga CT; Faber JC; Vesga MA; Selivanov E; Danilova T; Tadokoro K; Krusius T; Hafner V; Snopek I; Reali G; d'Almeida Gonçalves J
    Vox Sang; 1999; 77(2):110-20. PubMed ID: 10577259
    [No Abstract]   [Full Text] [Related]  

  • 12. Three years of haemovigilance in a general university hospital.
    Michlig C; Vu DH; Wasserfallen JB; Spahn DR; Schneider P; Tissot JD
    Transfus Med; 2003 Apr; 13(2):63-72. PubMed ID: 12694550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality assurance in blood transfusion: the advantages and limitations].
    Hergon E
    Transfus Clin Biol; 1998 Apr; 5 Suppl 1():36S-41S. PubMed ID: 9622844
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evolution of the practices of labile blood product distribution].
    Tardivel R
    Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced components.
    Dumont LJ
    Transfus Sci; 1998 Dec; 19(4):377-80. PubMed ID: 10351162
    [No Abstract]   [Full Text] [Related]  

  • 16. The case for standardization of transfusion medicine practices in French blood banks.
    Moncharmont P; Lacruche P; Planat B; Morizur A; Subtil E
    Transfus Med; 1999 Mar; 9(1):81-5. PubMed ID: 10216908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practice.
    Wiersum-Osselton JC; Faber JC; Politis C; Brand A; van der Bom JG; Schipperus MR
    Vox Sang; 2013 Apr; 104(3):214-7. PubMed ID: 23061879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [European regulation on blood and blood components].
    Sandid I
    Transfus Clin Biol; 2010 Dec; 17(5-6):310-4. PubMed ID: 21050786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemovigilance: a joint responsibility of hospitals and blood banks].
    van Aken WG
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1490-2. PubMed ID: 12924077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
    Chamfly V
    Transfus Sci; 1998 Dec; 19(4):333-42. PubMed ID: 10351148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.